Mydecine Innovations Group Files Amended and Restated Financial Statements

Author's Avatar
Feb 05, 2021
Article's Main Image

Mydecine Innovations Group Inc. (the “Company”) (CSE:MYCO | OTC:MYCOF) (FSE: 0NFA) announces it has filed amended and restated unaudited condensed interim consolidated financial statements for the nine-month period ended September 30, 2020 (the “Restated Statements”) and related amended and restated management discussion and analysis (“Restated MD&A”and together with the Restated Statements, the “Restated Documents”).